Local view for "http://purl.org/linkedpolitics/eu/plenary/2014-09-17-Speech-3-331-000"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20140917.26.3-331-000"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
"Mr President, earlier this year I led Parliament’s work on the European and Developing Countries’ Clinical Trials Partnership, which budgets more than EUR 600 million over seven years towards finding new cures and treatments for infectious diseases – diseases which, unless tackled at their source, pose an extreme risk to European citizens. I understand that the Commission is looking to fast-track some of this money into researching anti-viral drugs and vaccines for Ebola, and I hope that colleagues will support this.
No one can find cures to Ebola by themselves but this programme enables African partners to work with our own national researchers, both charitably funded researchers and private companies like Glaxo-Smith-Kline which, I understand, may have the most advanced potential vaccine for Ebola.
Ebola is a real and growing danger. We have researchers, who are experts, who are already out there and in our own countries researching new means of prevention and treatments. This programme has already looked at the ethical and other issues. We have the money in our budgets. Let us put it to good use and get it to the scientists right now."@en1
|
| lpv:spokenAs | |
| lpv:unclassifiedMetadata | |
| lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples